ArticleLupus science & medicine2025

Efficacy and safety of belimumab versus rituximab for refractory immune thrombocytopenia in patients with connective tissue disease.

Xiangning Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.